- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Immunotherapy Barriers: Multidisciplinary Approach in cSCC and BCC
Key opinion leaders underscore the importance of a multidisciplinary approach that can break down barriers and advance CSCC and BCC therapy.
EP: 1.Prevalence of Cutaneous Squamous Cell Carcinoma (CSCC) & Basal Cell Carcinoma (BCC)
EP: 2.Immunotherapy Landscape in cSCC and BCC
EP: 3.Immunotherapy and Radiation Therapy in cSCC and BCC
EP: 4.Immunotherapy Barriers: Multidisciplinary Approach in cSCC and BCC
EP: 5.Coordination of Care: Interdisciplinary Immunotherapy Challenges in Nonmelanoma Skin Cancers
EP: 6.Multidisciplinary Collaboration: Best Practices for CSCC and BCC Management
EP: 7.Dermatologists and Immunotherapy: Managing Patient Expectations
EP: 8.Monitoring Immunotherapy Toxicities in CSCC and BCC
EP: 9.Staging Disease and Risk Stratification in CSCC and BCC
EP: 10.Targeted Therapy: Hedgehog Inhibitors in BCC
EP: 11.Socioeconomic Implications of CSCC and BCC
EP: 12.Immunosuppression in CSCC and BCC Treatment
EP: 13.Updates in Therapeutics for Nonmelanoma Skin Cancers
EP: 14.Concluding Thoughts on the Future of CSCC and BCC Care
This is a video synopsis/summary of a Peer Exchange involving Jason Luke, MD, FACP; Christopher Barker, MD; Omid Hamid, MD; Vishal Patel, MD; and Catherine Pisano, MD.
Pisano cited physician inexperience with and hesitation about immunotherapy as barriers to its use in advanced cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC). She emphasized the importance of a multidisciplinary team to optimally administer immunotherapy and monitor adverse effects. Luke agreed and noted multidisciplinary tumor boards are less common for skin cancers than many other malignancies, highlighting the need for earlier involvement of medical oncology in cSCC/BCC care. Hamid emphasized that close coordination among oncology, surgery, radiation oncology, and other specialties enables optimal immunotherapy decision-making and toxicity monitoring from the outset rather than only at the time of unresectable disease. Patel added that the clinical courses of advanced skin cancers necessitate interdisciplinary care, given these diseases span multiple specialties. While dermatologists often have the longest relationship with patients, early input from medical oncology regarding evolving perioperative and radiation combination paradigms is critical in this rapidly moving treatment landscape to inform decisions along the entire patient journey.
Video synopsis is AI-generated and reviewed by AJMCÒ editorial staff.
Racial Differences in CA-125 Levels Tied to Ovarian Cancer Treatment Delays
April 17th 2025Black and American Indian women with ovarian cancer were less likely to have elevated cancer antigen 125 (CA-125) levels at diagnosis, resulting in delayed chemotherapy initiation and highlighting the need for more inclusive guidelines.
Read More
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
April 15th 2025Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.
Read More
